Novartis | Capitale Di Prestito



Loan Capital Cambiamento Data
AbbVie USD 64.53B 4.19B 2025-03
Amgen USD 53.76B 253M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Bausch Health Companies USD 20.86B 369M 2025-06
Biogen USD 6.28B 1.74B 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Canopy Growth CAD 289M 178.93M 2025-06
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 59.47M 3.74B 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Glaxosmithkline GBP 15.3B 667M 2025-06
J&J USD 38.36B 7.7B 2025-03
Merck USD 33.97B 484M 2025-06
Novartis USD 24.06B 2.4B 2025-06
Novartis USD 24.06B 1.13B 2025-06
Pacira USD 378.1M 3.2M 2025-06
Perrigo USD 3.62B 24.2M 2025-06
Pfizer USD 57.5B 137M 2025-06
Prestige Brands USD 1.01B 256K 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.2B 211M 2025-06
Sanofi 14.72B 2.93B 2025-06
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 5.23B 4M 2025-06


Novartis Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.